Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Why Index Level Rises Indicators explains the reasons behind rising index levels and how to respond with prudent actions.
23,291 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
A utilities-focused ETF has delivered defensive resilience through several recessions this century, as AI demand and ...
Ripple and North Island Ventures have led a $6 million funding round for Squid, the cross-chain platform, as the comp...
Analysts warn that the Social Security funding gap could reach a tipping point in the early 2030s. If policy action s...
New to real estate rehab? Build confidence and profits with five proven systems every rookie investor can adopt now. ...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
Crypto development is a high-stakes battleground for malware. This article explains how a perplexity built tool that ...
BP unexpectedly removes its chairman just months after his appointment, citing governance standards and conduct conce...
AI is moving from chat to your wallet. OpenAI has rolled a personal finance dashboard for Pro users, raising question...
Citigroup's Jane Fraser tops the 2026 Fortune Most Powerful Women list as 11 CFOs join the ranks, underscoring financ...
Goldman Sachs marks Nvidia and Micron as the leading AI winners ahead of the upcoming earnings season, triggering fre...